Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Scherzer

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Neurobiology of Disease|March 17, 2009
Chipping away at diagnostics for neurodegenerative diseasesClemens R Scherzer
Vision Research|April 17, 2012
Occlusion improves the interpolation of sampled motionTom R Scherzer, Vebjørn Ekroll
I-Perception|June 18, 2019
From Michotte Until Today: Why the Dichotomous Classification of Modal and Amodal Completions Is InadequateTom R Scherzer, Franz Faul
Perception|August 11, 2009
Apparent visual motion of the observer's own limbsVebjørn Ekroll, Tom R Scherzer
Journal of Vision|October 9, 2009
Intermittent occlusion enhances the smoothness of sampled motionTom R Scherzer, Vebjørn Ekroll
Journal of Vision|January 24, 2015
Partial modal completion under occlusion: what do modal and amodal percepts represent?Tom R Scherzer, Vebjørn Ekroll
Biomarkers in Medicine|May 19, 2010
RNA biomarkers of Parkinson's disease: developing tools for novel therapiesGerrit Hennecke, Clemens R Scherzer
Amino Acids|October 13, 2006
The five bromotryptophansS Bittner, R Scherzer, E Harlev
Trends in Genetics : TIG|June 29, 2004
Yeast genetics targets lipids in Parkinson's diseaseClemens R Scherzer, Mel B Feany
JAMA Neurology|May 1, 2018
Discovering New Benefits From Old Drugs With Big Data-Promise for Parkinson DiseaseAbby L Olsen, Trond Riise, Clemens R Scherzer
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Neurobiology of Disease|March 17, 2009
Chipping away at diagnostics for neurodegenerative diseasesClemens R Scherzer
Vision Research|April 17, 2012
Occlusion improves the interpolation of sampled motionTom R Scherzer, Vebjørn Ekroll
I-Perception|June 18, 2019
From Michotte Until Today: Why the Dichotomous Classification of Modal and Amodal Completions Is InadequateTom R Scherzer, Franz Faul
Perception|August 11, 2009
Apparent visual motion of the observer's own limbsVebjørn Ekroll, Tom R Scherzer
Journal of Vision|October 9, 2009
Intermittent occlusion enhances the smoothness of sampled motionTom R Scherzer, Vebjørn Ekroll
Journal of Vision|January 24, 2015
Partial modal completion under occlusion: what do modal and amodal percepts represent?Tom R Scherzer, Vebjørn Ekroll
Biomarkers in Medicine|May 19, 2010
RNA biomarkers of Parkinson's disease: developing tools for novel therapiesGerrit Hennecke, Clemens R Scherzer
Amino Acids|October 13, 2006
The five bromotryptophansS Bittner, R Scherzer, E Harlev
Trends in Genetics : TIG|June 29, 2004
Yeast genetics targets lipids in Parkinson's diseaseClemens R Scherzer, Mel B Feany
JAMA Neurology|May 1, 2018
Discovering New Benefits From Old Drugs With Big Data-Promise for Parkinson DiseaseAbby L Olsen, Trond Riise, Clemens R Scherzer
Pageof 14